NIH’s $110M Women’s Health Investment – Join PMWC 2025’s Women’s Health Track
Have you heard about the Historic $110M NIH Investment in Women’s Health?
Following the NIH’s announcement of this ARPA-H funding, the PMWC 2025 Silicon Valley (Feb 5-7 Program) Women’s Health Track is primed to spotlight innovations that align with this transformative support.
Join us on February 6th at the Santa Clara Convention Center for discussions on breakthroughs from maternal health to Alzheimer’s:
Honoring Dr. Diana Bianchi
We are thrilled to honor Dr. Diana Bianchi with the PMWC Luminary Award for her pioneering advancements in non-invasive prenatal testing (NIPT), supported by NIH research insights. Her work has expanded NIPT’s reach, identifying both fetal conditions and maternal genomic insights linked to oncology and autoimmune disorders.
Honoring Dr. Nanette K. Wenger
PMWC 2025 proudly names Dr. Nanette K. Wenger as the Pioneer Honoree for her decades-long dedication to advancing women’s cardiovascular health. Her transformative research has redefined medical understanding and protocols, inspiring further study into sex-based differences.
Endometriosis, Fertility, and Endocrinological Problems
Building on transformative healthcare, Dr. Linda Giudice (UCSF) will present her NIH-funded research on repurposed drugs that show promise in reducing endometriosis-associated pain. This session will highlight endometriosis’ impact on fertility. Dr. Paolo Rinaudo (UCSF) will explore data-driven methods for enhancing fertility research and treatments, while Dr. Vittorio Sebastiano (Stanford) will delve into the role of stem cells in fertility and aging. Dr. Ruth Bunker Lathi (Stanford) will provide insights into differentiating maternal and fetal causes of miscarriage to improve outcomes. Lastly, Dr. Aleksandar Rajkovic (UCSF) will discuss genetic insights into uterine fibroids and their effect on fertility.
Cardiovascular Health and Alzheimer’s Disease in Women
We are also proud to announce Dr. Nanette K. Wenger as our Pioneer Honoree. Her contributions to cardiology have transformed the understanding and treatment of cardiovascular disease in women, reshaping medical guidelines and advancing women’s cardiovascular care. This session, chaired by Dr. Noel Bairey Merz (Cedars-Sinai), will feature a panel of leading experts: Dr. Janet Wright (CDC), Dr. Christine Albert (Cedars-Sinai), Dr. Judy Regensteiner (University of Colorado), Dr. Garima Sharma (Inova Health System), and Dr. Roxana Mehran (Mount Sinai), who will share the latest research findings. Additionally, the session on Innovations in Alzheimer’s and Women’s Health will focus on neurological conditions affecting women, featuring Dr. Aparna Vasanthakumar (AbbVie) and Dr. Duygu Tosun-Turgut (UCSF).
Pregnancy and Multi-Omics Advances
The session titled “Harnessing Pre-Pregnancy Data to Predict Pregnancy Health” will showcase Dr. Priya Pantham (UCSD) and her work on RNA-based biomarker discovery for gestational diseases. Dr. Mike Snyder (Stanford) will present on the role of biological clocks in pregnancy using multi-omics analysis, and Dr. Alison Paquette (Seattle Children’s Research Institute) will discuss the multi-omics analysis of the placenta and its implications for pregnancy health. The Q&A session will be moderated by Dr. Yoel Sadovsky (University of Pittsburgh).
Join Us in Transforming Women’s Health: Be part of this dynamic track, designed for healthcare professionals, researchers, and industry leaders. Engage with the foremost minds in women’s health as we accelerate innovations inspired by this unprecedented funding boost.
Register for PMWC 2025 Silicon Valley Feb 5-7 to join the Women’s Health and 11 other tracks.
Save 50% by Thursday
Best regards,
Tal Behar
President & Co-founder, PMWC
PMWC 2025 Silicon Valley – February 5-7, 2025
